ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Bacterial infections"

  • Abstract Number: 2873 • 2019 ACR/ARP Annual Meeting

    Antimicrobial Use Is High in Patients with Rheumatoid Arthritis, and Further Increases with First-Line TNFi Therapy – Nationwide Results from Iceland

    Aron H Bjornsson1, Olafur Palsson 2, Mar Kristjansson 3, Petur S Gunnarsson 4, Gerdur Grondal 5, Bjorn Gudbjornsson 6 and Thorvardur J Love 7, 1Department of Medicine, Landspitali, Reykjavík, Iceland, 2Department of Clinical Sciences Lund, Lund University and Skåne University Hospital, Lund, Sweden, 3Department of Infectious Diseases, Landspitali, Reykjavík, Iceland, 4Faculty of Pharmaceutical Sciences, University of Iceland and Hospital Pharmacy, Landspitali, Reykjavík, Iceland, 5Department of Rheumatology, Landspitali and Centre for Rheumatology Research, Landspitali, Reykjavík, Iceland, 6Centre for Rheumatology Research, Landspitali and Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 7Faculty of Medicine, University of Iceland and Department of Science, Landspitali, Reykjavík, Iceland

    Background/Purpose: Severe infections, frequently resulting in hospitalization, are a well-known adverse effects of tumor necrosis factor inhibitors (TNFi). However, studies regarding outpatient treated infections are…
  • Abstract Number: 942 • 2018 ACR/ARHP Annual Meeting

    Risk of Serious Infections in Tocilizumab Versus TNF Inhibitor Initiators in Patients with RA: A Multi-Database Cohort Study

    Ajinkya Pawar1, Rishi J. Desai2, Daniel Solomon1, Sara Gale3, Min Bao4, Khaled Sarsour3, Sebastian Schneeweiss1 and Seoyoung C. Kim1, 1Brigham and Women's Hospital, Boston, MA, 2Division of Pharmacoepidemiology and Pharmacoeconimics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Genentech, South San Francisco, CA, 4Roche Innovation Center, New York, NY

    Background/Purpose: While biologics are known to be associated with risk of serious infections, data on head-to-head comparison of different biologic drugs for the risk of…
  • Abstract Number: 1238 • 2018 ACR/ARHP Annual Meeting

    The Effect of Antibiotic Therapy on Positive Culture Results Among Patients with Prosthetic Joint Septic Arthritis

    Efrat Gur Rosset1, Mary Louise Fowler2, Sarah Lieber3, Robert Shmerling4 and Ziv Paz3,5,6, 1Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel, 2Boston University School of Medicine, Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 5Galilee Medical Center, Nahariya, Israel, 6Azrieli Faculty of Medicine, Bar-Ilan University, Sefad, Israel

    Background/Purpose: Little is known about the effects of antibiotic therapy on synovial and blood culture results among patients with prosthetic joint septic arthritis (PJSA). In…
  • Abstract Number: 1239 • 2018 ACR/ARHP Annual Meeting

    Organisms Associated with Prosthetic Joint Septic Arthritis over the Past Two Decades: Data from a Single Tertiary Medical Center Located in the Northeastern United States

    Manny Menachem Arieli1, Mary Louise Fowler2, Sarah Lieber3, Robert Shmerling4, Mohammad Naffaa5 and Ziv Paz1,3, 1Azrieli Faculty of Medicine, Bar-Ilan University, Sefad, Israel, 2Boston University School of Medicine, Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 5Galilee Medical Center, Israel, Naharriya, Israel

    Background/Purpose: In recent years, joint replacement surgery (JRS) has become increasingly common. Prosthetic joint septic arthritis (PJSA) may complicate JRS in up to 1% of…
  • Abstract Number: 1883 • 2018 ACR/ARHP Annual Meeting

    Infections Are Associated With Increased Risk of Giant Cell Arteritis – a Population-Based Case-Control Study From Southern Sweden

    Pavlos Stamatis1, Aleksandra Turkiewicz2, Martin Englund2, Goran Jönsson3, Jan-Åke Nilsson4, Carl Turesson5 and Aladdin Mohammad6, 1Clinical Sciences, Rheumatology Lund, Lund University, Lund, Sweden, 2Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, Lund, Sweden, 3Clinical Sciences Lund, Department of Infection Medicine, Lund University, Lund, Sweden, 4Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 5Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 6Rheumatology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden

    Background/Purpose: Previous studies have implicated infections as a risk factor for giant cell arteritis (GCA). The purpose of this study was to investigate the association…
  • Abstract Number: 2453 • 2018 ACR/ARHP Annual Meeting

    Staphylococcus Aureus Carriage Rates Are High in Rheumatoid Arthritis Patients on Biologics

    Susan M. Goodman1, Bo Shopsin2, Allina A. Nocon1, Andy O. Miller3, Michael W. Henry3, Sarah E. Grond1, Elianna Kaplowitz1, Thomas P. Sculco4, Linda A. Russell3, Laura T. Donlin5, Mark P. Figgie4 and Peter K. Sculco4, 1Hospital for Special Surgery, New York, NY, 2Medicine and Microbiology, New York University School of Medicine, New York, NY, 3Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 4Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 5Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Patients with rheumatoid arthritis (RA) have a higher risk of surgical site infection  than patients with osteoarthritis (OA). Disease modifying therapy is widely used…
  • Abstract Number: 1317 • 2016 ACR/ARHP Annual Meeting

    Do Patients with MRSA-Positive Septic Arthritis Differ Clinically from Non-MRSA-Positive Counterparts?

    Mary Louise Fowler1, Kevin Byrne1, Sarah B. Lieber2, Andy Moore3, Robert Shmerling4 and Ziv Paz2, 1Boston University School of Medicine, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA, 3Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, 4Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA

    Do patients with MRSA-positive septic arthritis differ clinically from non-MRSA-positive counterparts? Mary Louise Fowler3, Kevin Byrne3, Sarah B. Lieber1, Andrew Moore2, Robert H. Shmerling1, Ziv…
  • Abstract Number: 1354 • 2015 ACR/ARHP Annual Meeting

    Whipple’s Disease: The Diagnostic Utility of Synovial Fluid Tropheryma Whipplei Polymerase Chain Reaction

    Zoran Kvrgic1, Kelly Cawcutt2, Robin Patel3, Abinash Virk2, Clement J. Michet Jr.4, Eric L. Matteson5 and Tim Bongartz1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Infectious Diseases, Mayo Clinic, Rochester, MN, 3Medicine, Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: Inflammatory arthritis is a common, non-specific symptom of Whipple’s disease. Recovery of the organism by conventional culture is often unsuccessful. Synovial fluid polymerase chain…
  • Abstract Number: 2851 • 2015 ACR/ARHP Annual Meeting

    Anti-TNF Therapy Is Associated with an Increase in Serious Infections in Patients with Spondyloarthritis (SpA), Especially during the First 12 Monts of Treatment: Results from the GISEA Registry

    Fabiola Atzeni1, Marco Sebastiani2, Valentina Panetta3, Fausto Salaffi4, Antonio Marchesoni5, Roberta Ramonda6, Florenzo Iannone7, Roberto Gorla8, Elisa Gremese9, Marcello Govoni10, Pier Carlo Sarzi-Puttini11, Gianfranco Ferraccioli12, Giovanni Lapadula13 and on behalf of GISEA group, 1Rheumatology Unit, L. Sacco University Hospital of Milan, Milan, Italy, 2SC Reumatologia, Dipartimento di Medicine, Medicina d’Urgenza e Specialità Mediche, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy, 3L'altrastatistica -Consultancy & Training- Biostatistics office., Rome, Italy, 4Rheumatology Department, Polytechnic University of Marche, C. Urbani Hospital, Jesi,, Ancona, Italy, 5Day Hospital of Rheumatology, G. Pini Orthopedic Institute, Chair of Rheumatology of Milan, Milan, Italy, 6Cattedra, Voc Rheumatology, University of Padua, Padova, Italy, 7Interdisciplinary Department of Medicine (DIM), Rheumatology Unit, University of Bari, Bari, Italy, 8Rheumatology and Immunology Unit, Spedali Civili di Brescia, Brescia, Italy, 9Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 10Department of Medical Sciences, UOC of Rheumatology, Azienda Ospedaliero-Universitaria S. Anna-Ferrara, University of Ferrara, Cona Ferrara, Italy, 11Rheumatology Unit, University Hospital L Sacco, Milan, Italy, 12Rheumatology and Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy, 13Bari University, Rheumatology, Bari, Italy

    Background/Purpose: Infection is by far the most common and most important adverse effect of TNF inhibitors (TNFI) in the treatment of  rheumatoid arthritis (RA) and…
  • Abstract Number: 2153 • 2014 ACR/ARHP Annual Meeting

    Clinical Characteristics and Outcomes in Synovial Fluid Culture ̵ Negative Septic Arthritis

    Sarah B. Lieber, Ziv Paz and Robert H. Shmerling, Beth Israel Deaconess Medical Center, Boston, MA

    Background/Purpose: Delays in diagnosis and treatment of septic arthritis may be associated with significant morbidity. While many patients with suspected or proven septic arthritis are…
  • Abstract Number: 936 • 2014 ACR/ARHP Annual Meeting

    Active Invasion of Periodontal Bacteria into Synovial Joint Exacerbates Collagen-Induced Arthritis in Disease-Prone B10 Riii Mice

    Sasanka Chukkapalli1, Mercedes Rivera-Kweh1, Irina Velsko1, Indraneel Bhattacharyya2, S. John Calise3, Edward Chan4, Minoru Satoh5 and Lakshmyya Kesavalu1, 1Periodontology, College of Dentistry, University of Florida, Gainesville, FL, 2Oral Diagnostic Sciences, College of Dentistry, University of Florida, Gainesville, FL, 3Oral Biology, University of Florida, Gainesville, FL, 4Oral Biology, College of Dentistry, University of Florida, Gainesville, FL, 5Clinical Nursing, Univ. Occupational and Environmental Health, Kitakyushu, Fukuoka, FL, Japan

    Background/Purpose: Periodontitis (PD) is a chronic immunoinflammatory disease caused by complex subgingival periodontal bacteria. Rheumatoid Arthritis (RA) and PD both are chronic inflammatory disorders characterized…
  • Abstract Number: 2895 • 2013 ACR/ARHP Annual Meeting

    Bacterial Amyloids Promote Type I Interferon Production and Accelerate Autoimmunity

    Paul Gallo, Glenn Rapsinski, Cagla Tukel and Stefania Gallucci, Dept. of Microbiology and Immunology, Laboratory of Dendritic Cell Biology, Temple Autoimmunity Center, Temple University School of Medicine, Philadelphia, PA

    Background/Purpose: Infection is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE).  This is largely due to the use of…
  • Abstract Number: 1580 • 2013 ACR/ARHP Annual Meeting

    Drug-Resistant Bloodstream Infections In Systemic Lupus Erythematosus Patients: A Clinical Perspective

    Ana Barrera-Vargas1, Diana Gómez-Martín1, Alfredo Ponce de León2 and Jorge Alcocer-Varela1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Department of Infectology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: Infections are an important cause of mortality and morbidity in Systemic Lupus Erythematosus (SLE) patients. Different risk factors have been described for the development…
  • Abstract Number: 2524 • 2012 ACR/ARHP Annual Meeting

    Snapin Is Critical for the Maturation of Autophagosome and Phagosome in Macrophages

    Bo Shi1, Qiquan Huang2, Robert Birkett1, Renee E. Koessler3, Andrea Dorfleutner4, Christian Stehlik4 and Richard M. Pope5, 1Division of Rheumatology, Department od Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL, 4Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose:  We found that Snapin, a SNARE complex protein required for synaptic vesicle docking and fusion, was significantly increased in rheumatoid arthritis (RA) synovial tissue…
  • Abstract Number: 1197 • 2012 ACR/ARHP Annual Meeting

    Porphyromonas Gingivalis and the Pathogenesis of Rheumatoid Arthritis: Analysis of the Synovial Tissue and of Other Compartments

    Michele C. Totaro1, Sara D'Onghia2, Elisa Gremese1, Luca Petricca1, Simona Marchetti2, Silvia Canestri1, Barbara Tolusso1, Stefano Alivernini1, Paola Cattani2 and Gianfranco Ferraccioli1, 1Division of Rheumatology, Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy, 2Laboratory of Clinical Analyses CIC, Catholic University of the Sacred Heart, Rome, Italy

    Background/Purpose: Porphyromonas gingivalis (Pg), a periodontal anaerobic intracellular pathogen, has been recently associated to rheumatoid arthritis (RA) and the pathogenesis of the disease, due to…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology